"Other than the increase to the maximum tender offer amount, all other terms and conditions of the tender offers, as previously announced, remain unchanged. Dave Denton, executive vice president and chief financial officer stated: "Through this transaction as well as our recent debt issuance, we are taking advantage of the current favorable interest rate environment. This debt refinancing will enhance our long-term debt structure and decrease our interest expense going forward."
There's more good news for shareholders, but first let's look at a one-year chart of the share price of CVS as well as its PE value, which has risen in tandem with the price-per-share.
CVS data by YCharts
The valuation of CVS stock looks attractive with a forward (one-year) PE of around 12 and an attractive price-to-earnings-growth (PEG) ratio (five-year expected) of only 1.04. The dividend seems paltry to me at only a yield-to-price of 1.38%, but that's where this story and this stock becomes more interesting.Argus Research recently reported its opinion that CVS may be prepared to raise the dividend by up to 15% at the upcoming analyst meeting Thursday. Argus apparently believes the outcome of the meeting may move CVS's stock price. Argus and Cantor Fitzgerald maintain a "buy" rating on CVS. Will CVS raise itsdividend Thursday at the analyst meeting? I think there's every reason to believe that it will -- if it doesn't, shares may plummet in disappointment. If you're interested in taking a position, you may want to nail down a few shares before the meeting and the rest afterwards. Nineteen analysts have a consensus earnings estimate on this quarter (ending this month) of $1.10 per share, which would be a 23.6% increase over the year-ago quarter. The consensus estimate on revenue for this quarter is over $31 billion. Expectations for CVS are reasonable, management appears to be prudent and proactive and the twin investment themes of ongoing bottom line growth and improving debt maintenance bode well. Do your own careful due diligence before investing, and watch your trailing stops if you own the stock. At the time of publication the author had no position in any of the stocks mentioned. This article was written by an independent contributor, separate from TheStreet's regular news coverage. Jim Cramer and Stephanie Link actively manage a real money portfolio for his charitable trust- enjoy advance notice of every trade, full access to the portfolio, and deep coverage of the latest economic events and market movements.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV